CN104987359B - 一种鹿茸蛋白提取物及其应用、药物制剂 - Google Patents
一种鹿茸蛋白提取物及其应用、药物制剂 Download PDFInfo
- Publication number
- CN104987359B CN104987359B CN201510487130.7A CN201510487130A CN104987359B CN 104987359 B CN104987359 B CN 104987359B CN 201510487130 A CN201510487130 A CN 201510487130A CN 104987359 B CN104987359 B CN 104987359B
- Authority
- CN
- China
- Prior art keywords
- pilose antler
- protein extract
- buffer solution
- pilose
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000003056 antler Anatomy 0.000 title claims abstract description 188
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 119
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 119
- 239000000284 extract Substances 0.000 title claims abstract description 99
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract description 7
- 239000007853 buffer solution Substances 0.000 claims abstract description 56
- 238000002360 preparation method Methods 0.000 claims abstract description 34
- 238000009777 vacuum freeze-drying Methods 0.000 claims abstract description 22
- 239000008280 blood Substances 0.000 claims abstract description 15
- 210000004369 blood Anatomy 0.000 claims abstract description 15
- 239000006228 supernatant Substances 0.000 claims abstract description 14
- 238000004108 freeze drying Methods 0.000 claims abstract description 13
- 238000002137 ultrasound extraction Methods 0.000 claims abstract description 6
- 241001631271 Prunus fasciculata Species 0.000 claims description 32
- 238000002604 ultrasonography Methods 0.000 claims description 25
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 11
- 239000000872 buffer Substances 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 241000282994 Cervidae Species 0.000 claims description 8
- 239000007983 Tris buffer Substances 0.000 claims description 6
- 239000002398 materia medica Substances 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 6
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 5
- 240000002853 Nelumbo nucifera Species 0.000 claims description 5
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 5
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000007924 injection Substances 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 230000035755 proliferation Effects 0.000 abstract description 18
- 238000000034 method Methods 0.000 abstract description 17
- 238000000605 extraction Methods 0.000 abstract description 15
- 230000012010 growth Effects 0.000 abstract description 12
- 230000004663 cell proliferation Effects 0.000 abstract description 9
- 230000008569 process Effects 0.000 abstract description 6
- 230000010261 cell growth Effects 0.000 abstract description 5
- 210000003606 umbilical vein Anatomy 0.000 abstract description 5
- 210000005167 vascular cell Anatomy 0.000 abstract description 5
- 210000002919 epithelial cell Anatomy 0.000 abstract description 4
- 210000004027 cell Anatomy 0.000 description 23
- 239000002994 raw material Substances 0.000 description 15
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- 238000005119 centrifugation Methods 0.000 description 11
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 10
- 230000000694 effects Effects 0.000 description 8
- 230000003698 anagen phase Effects 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 230000009514 concussion Effects 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 238000007710 freezing Methods 0.000 description 6
- 230000008014 freezing Effects 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- 238000001962 electrophoresis Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 239000003102 growth factor Substances 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 102400001368 Epidermal growth factor Human genes 0.000 description 3
- 101800003838 Epidermal growth factor Proteins 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 235000013601 eggs Nutrition 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 229940116977 epidermal growth factor Drugs 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 230000003204 osmotic effect Effects 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000003680 myocardial damage Effects 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000005057 refrigeration Methods 0.000 description 2
- 238000010129 solution processing Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 210000004885 white matter Anatomy 0.000 description 2
- 239000012224 working solution Substances 0.000 description 2
- PFKYCGAUNWCWNO-UHFFFAOYSA-N 1,5-diphenyl-1h-tetrazol-1-ium;bromide Chemical compound [Br-].C1=CC=CC=C1[NH+]1C(C=2C=CC=CC=2)=NN=N1 PFKYCGAUNWCWNO-UHFFFAOYSA-N 0.000 description 1
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 1
- 125000000972 4,5-dimethylthiazol-2-yl group Chemical group [H]C([H])([H])C1=C(N=C(*)S1)C([H])([H])[H] 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- XJLXINKUBYWONI-NNYOXOHSSA-O NADP(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-O 0.000 description 1
- 108010025020 Nerve Growth Factor Proteins 0.000 description 1
- 102000015336 Nerve Growth Factor Human genes 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 210000004292 cytoskeleton Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 229940053128 nerve growth factor Drugs 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000004885 tandem mass spectrometry Methods 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Abstract
Description
Type of search | MS/MS Ion Search |
Enzyme | Trypsin |
Variable modifications | Oxidation(M) |
Mass values | Monoisotopic |
Protein mass | Unrestricted |
Peptide mass tolerance | ±0.03 Da |
Fragment mass tolerance | ±0.03 Da |
Max missed cleavages | 2 |
Instrument type | ESI-QUAD-TOF |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510487130.7A CN104987359B (zh) | 2015-08-10 | 2015-08-10 | 一种鹿茸蛋白提取物及其应用、药物制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510487130.7A CN104987359B (zh) | 2015-08-10 | 2015-08-10 | 一种鹿茸蛋白提取物及其应用、药物制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104987359A CN104987359A (zh) | 2015-10-21 |
CN104987359B true CN104987359B (zh) | 2018-11-20 |
Family
ID=54299275
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510487130.7A Active CN104987359B (zh) | 2015-08-10 | 2015-08-10 | 一种鹿茸蛋白提取物及其应用、药物制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104987359B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107308504A (zh) * | 2017-06-17 | 2017-11-03 | 常州帝君金属构件厂 | 一种心肌仿生支架的制备方法 |
CN109485692A (zh) * | 2018-12-06 | 2019-03-19 | 吉林农业大学 | 一种提取鹿茸中活性蛋白的方法 |
CN112494518A (zh) * | 2020-11-18 | 2021-03-16 | 中科健康产业集团股份有限公司 | 一种鹿茸酒的制备方法 |
CN113603762B (zh) * | 2021-08-20 | 2023-06-27 | 吉林农业大学 | 一种花马杂交鹿鹿角盘活性肽及其制备方法和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1104095A (zh) * | 1993-12-24 | 1995-06-28 | 霍玉书 | 鹿茸生长因子制剂及工艺 |
WO2004106372A1 (en) * | 2003-05-27 | 2004-12-09 | Velvet Antler Research New Zealand Limited | Deer antler extract for promoting angiogenesis |
CN104288180A (zh) * | 2014-09-10 | 2015-01-21 | 河南辅仁堂制药有限公司 | 一种鹿茸纯粉的制备方法 |
-
2015
- 2015-08-10 CN CN201510487130.7A patent/CN104987359B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1104095A (zh) * | 1993-12-24 | 1995-06-28 | 霍玉书 | 鹿茸生长因子制剂及工艺 |
WO2004106372A1 (en) * | 2003-05-27 | 2004-12-09 | Velvet Antler Research New Zealand Limited | Deer antler extract for promoting angiogenesis |
CN104288180A (zh) * | 2014-09-10 | 2015-01-21 | 河南辅仁堂制药有限公司 | 一种鹿茸纯粉的制备方法 |
Non-Patent Citations (3)
Title |
---|
Deer antlers-traditional use and future perspectives;Kawtikwar P S,et al.;《《Indian Journal of Traditional Knowledge》;20100430;第9卷(第2期);第245-251页 * |
冻鲜马鹿茸蛋白成分的分离与活性初探;潘思羽;《中国优秀硕士学位论文全文数据库 医药卫生科技辑》;20101215(第12期);第8页1.2.1.1,第38-39页2.4 * |
梅花鹿茸可溶性蛋白提取工艺及免疫活性;张梦莹等;《东北林业大学学报》;20140930;第42卷(第9期);摘要,第159页1.3.1-1.3.5,第158页左栏第1段 * |
Also Published As
Publication number | Publication date |
---|---|
CN104987359A (zh) | 2015-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104987358B (zh) | 一种鹿茸蛋白提取物的制备方法 | |
CN104987359B (zh) | 一种鹿茸蛋白提取物及其应用、药物制剂 | |
CN111821252A (zh) | 一种含脂肪干细胞提取物的抗皱精华液及其制备方法 | |
CN108486047A (zh) | 一种干细胞提取物的医用敷料及其制备方法 | |
CN110772454A (zh) | 亮肤保湿、舒缓、抗衰老的复合精油、其制备方法及应用 | |
CN108703931A (zh) | 一种具有保湿作用的组合物及其制备方法 | |
CN103462865B (zh) | 从动物胚胎皮肤及肌肉中提取的胚胎素水提取物及其提取方法和用途 | |
US20210393501A1 (en) | Preparation method and application of recombinant mutant collagenase | |
US20220287952A1 (en) | Compositions containing exosomes from animal placenta, methods for producing the same and uses thereof | |
CN113122604B (zh) | 一种海肠胶及其制备方法和应用 | |
CN105232600B (zh) | 一种人参籽提取物及其制备方法和应用 | |
CN112294867B (zh) | 荔枝草黄芩复方痤疮乳膏剂及其制备方法与应用 | |
CN101948439B (zh) | 鹿茸活性生物碱类化合物的提取方法及在医药上的应用 | |
CN110317774A (zh) | 中草药的水性萃出物及其组合物与用途 | |
CN110526958B (zh) | 一种活力修复肽Tvigour A及其应用 | |
CN102274241B (zh) | 提取羊胚胎提取物的方法及含有该提取物的药物组合物 | |
CN102397175A (zh) | 一种祛除面部红血丝的中药提取物及其制备方法与应用 | |
CN109453104A (zh) | 淡斑爽肤精华液及其制备工艺 | |
CN110354154A (zh) | 一种可缓解干燥性皮肤炎症的沙枣多糖提取物及制备方法 | |
CN110183522A (zh) | 一种具有抗抑郁功能的糖肽及其制备方法与应用 | |
CN112708652B (zh) | 一种牛油果水包油液态发酵产品及其制备方法和应用 | |
CN108542877A (zh) | 一种皮米级细胞提取物的制备方法 | |
CN110452313B (zh) | 一种精制植物多糖、制备方法及在制备化妆品方面的应用 | |
Rangsimawong et al. | Extraction method of protein and insulin-like growth factor-1 from deer antler velvets for skin rejuvenation | |
CN115737572B (zh) | 一种胎盘粉及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 130012 1st floor, unit 10, building 10, Chaoda Pioneer Park, 3355 Silicon Valley Street, high tech Zone, Changchun City, Jilin Province Patentee after: Zhongke Yushen (Jilin) Technology Co.,Ltd. Country or region after: China Address before: 130012 1st floor, unit 10, building 10, Chaoda Pioneer Park, 3355 Silicon Valley Street, high tech Zone, Changchun City, Jilin Province Patentee before: JILIN YUSEN PHARMACEUTICAL TECHNOLOGY Co.,Ltd. Country or region before: China |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240125 Address after: Room 208, 2nd Floor, G1 Building, Phase II, Beihu Science and Technology Industrial Park, Beihu Science and Technology Development Zone, Changchun City, Jilin Province, 130012 Patentee after: Zhongke Qiangshen (Jilin) Technology Co.,Ltd. Country or region after: China Address before: 130012 1st floor, unit 10, building 10, Chaoda Pioneer Park, 3355 Silicon Valley Street, high tech Zone, Changchun City, Jilin Province Patentee before: Zhongke Yushen (Jilin) Technology Co.,Ltd. Country or region before: China |